Browse > Article
http://dx.doi.org/10.3831/KPI.2011.14.4.033

A Case Report for Lung Cancer Patient Showing Remission Treated with Cultivated Wild Ginseng Pharmacopuncture  

Kim, Koo (Department of Sasang Constitutional Medicine, Wonkwang University College of Oriental Medicine)
Choi, Yong-Seok (Department of Internal Medicine, Wonkwang University College of Oriental Medicine)
Joo, Jong-Cheon (Department of Sasang Constitutional Medicine, Wonkwang University College of Oriental Medicine)
Moon, Goo (Department of Internal Medicine, Wonkwang University College of Oriental Medicine)
Publication Information
Journal of Pharmacopuncture / v.14, no.4, 2011 , pp. 33-37 More about this Journal
Abstract
Objectives: To report the effect of cultivated wild ginseng pharmacopuncture on the lung cancer patient. Methods: Treatment of cultivated wild ginseng pharmacopuncture was conducted on the patient during 7 months. Pharmacopuncture therapy was done twice a week with a dosage of 2ml per each treatment. Computed Topography(CT) was performed to evaluate the therapeutic efficacy. Results: After the treatment of 7 months, chest CT revealed the mass size was decreased. Conclusions: This case provides us a possibility that cultivated wild ginseng pharmacopuncture offers potential benefits for lung cancer patient.
Keywords
cancer; cultivated wild ginseng; pharmacopuncture; squamous cell lung carcinoma;
Citations & Related Records
Times Cited By KSCI : 10  (Citation Analysis)
연도 인용수 순위
1 Kwon KR. Anticancer effect of mountain ginseng pharmacopuncture to the nude mouse of lung carcinoma induced by NCI-H460 human non-small cell lung cancer cells. Journal of Pharmacopuncture. 2010;13(1):5-14.   과학기술학회마을   DOI   ScienceOn
2 Kwon KR, Cho AL, Lee SG. The study on acute and subacute toxicity and anti-cancer effects of cultivated wild ginseng herbal acupuncture. Journal of Pharmacopuncture. 2003;6(2):7-27.   과학기술학회마을   DOI   ScienceOn
3 Kown KR, Park CW, Ra MS, Cho CK. Clinical observation of multiple metastatic cancer patient with hepatocellular carcinoma treated with cultivated wild ginseng herbal acupuncture therapy. J Korean Acupunct Moxibust Soc. 2005;22(2):211-217.   과학기술학회마을
4 Yu SM, Eo WK, Yoon SW. One case report of non-small cell lung cancer patients treated with allergen removed Rhus Verniciflua Stokes (aRVS). J of Kor Traditional Oncology. 2008;13(1):63-69.   과학기술학회마을
5 Park BK, Cho CK, Kwon KR, Yoo HS. A case report for stage IIIB squamous cell lung carcinoma patient treated with cultured wild ginseng pharmacopuncture therapy. Journal of Pharmacopuncture.2007;10(3):143-147.   DOI   ScienceOn
6 Bang SH, Kwon KR, Yoo HS. Two cases of non-small cell lung cancer treated with intravenous cultivated wild ginseng pharmacopuncture. Journal of Pharmacopuncture. 2008;11(2):13-19.   과학기술학회마을   DOI   ScienceOn
7 Kumar T, Patel N, Talwar A. Spontaneous regression of thoracic malignancies. Respir Med. 2010;104(10):1543-1550.   DOI   ScienceOn
8 Lee JH, Kwon KR, Cho CK, Han SS, Yoo HS. Advanced cancer cases treated with cultivated wild ginseng pharmacopuncture. J Acupunct Meridian Stud. 2010;3(2):119-124.   DOI
9 Kwon KR, Kim HD, Kim JS, Yoo HS, Cho CK. Case series of non-small cell lung cancer treated with mountain ginseng pharmacopuncture. J Acupunct Meridian Stud. 2011;4(1):61-68.   DOI
10 Antonio B, Sonia A, Jose LS, Jose LGA, Isabel B. The universal dynamics of tumor growth. Biophys J. 2003;85(5):2948-2961.   DOI   ScienceOn
11 Yoo HS, Bang SH, Cho CK. A recent study of anti-tumor herbal acupuncture in Korea. Journal of Pharmacopuncture. 2006;9(3):79-88.   DOI
12 Lim SY, Lee SJ, Kwon KR. Anti-cancer and immune promoting effects of cultivated wild ginseng herbal acupuncture on hepatic metastatic model using Colon26-L5 carcinoma cells. J Korean Acupunct Moxibust Soc. 2006;23(1):121-134.   과학기술학회마을
13 National statistical office. Republic of Korea Annual report on the cause of death statistics. http://www.kosis.kr. accessed on 2011/6/30.
14 Gridelli C, Ardizzoni A, Douillard JY, Hanna N, Manegold C, Perrone F, Pirker R, Rosell R, Shepherd FA, De Petris L, Ki Maio M, de Marinis F. Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an international expert panel meeting of the Italian Association of Thoracic Oncology. Lung Cancer. 2010;68(3);319-331.   DOI   ScienceOn
15 Kobayashi K. Guide line for the treatment of stage I and stage II non small cell lung cancer. Nippon Geka Gakkai Zasshi. 2004;105(7):392-403.
16 Kasper, Braunwald, Fauci, Hauser, Longo, Jameson. Harrison's principles of internal medicine. 16th edition, Seoul:MIP. 2006:546-559.
17 Rozencweig M, Von Hoff DD, Staquet MJ, Schein PS, Penta JS, Goldin A, Muggia FM, Freireich EJ, DeVita VT. Animal toxicology for early clinical trials with anticancer agents. Cancer Clin Trials. 1981;4(1):21-28.
18 Harris P, Finlay IG, Cook A, Thomas KJ, Hook K. Complementary and alternative medicine use by patients with cancer in Wales: a cross sectional survey. Complement Ther Med. 2003;11(4):249-253.   DOI   ScienceOn
19 Park SC, Yoo HS, Cho CK, Lee YW. Recent experimental tendency for herbal medicines treating lung cancer in South Korea. J of Kor Traditional Oncology. 2008;13(1):43-54.   과학기술학회마을
20 Yoo SH, Yoo HS, Cho CK, Lee YW. A case report for recurred squamous cell lung carcinoma treated with Hang-Am-Dan: 7 year follw up. Korean J Orient Int Med. 2007;28(2);385-390.